Literature DB >> 7915275

Zinc salts for the treatment of olfactory and gustatory symptoms in psychiatric patients: a case series.

A L Stoll1, G Oepen.   

Abstract

BACKGROUND: Zinc salts have been used extensively in medical settings to treat disorders of gustatory and olfactory function. However, zinc supplements have not been tested in psychiatric patients with smell or taste symptoms.
METHOD: The authors examined the effects of zinc supplements on five consecutive patients with symptoms of abnormal taste and smell perception in the context of acute psychiatric illness or treatment.
RESULTS: All five patients had complete or partial amelioration of these olfactory and gustatory symptoms after treatment with zinc sulfate or zinc gluconate, apparently independent of the improvement in their underlying psychiatric disorder.
CONCLUSION: We recommend treating unusual olfactory and gustatory symptoms with zinc salts, independent of the treatment for the underlying psychiatric disorder.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7915275

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

1.  Cranial nerve I: olfaction.

Authors:  Richard D Sanders; Paulette Marie Gillig
Journal:  Psychiatry (Edgmont)       Date:  2009-07

2.  Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy.

Authors:  Karla Sánchez-Lara; Ricardo Sosa-Sánchez; Dan Green-Renner; Cindy Rodríguez; Alessandro Laviano; Daniel Motola-Kuba; Oscar Arrieta
Journal:  Nutr J       Date:  2010-03-24       Impact factor: 3.271

3.  Re-establishment of olfactory and taste functions.

Authors:  Antje Welge-Lüssen
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

4.  The neuroplastic effect of olfactory training to the recovery of olfactory system in mouse model.

Authors:  Boo-Young Kim; Ju Yeon Park; Eui Jin Kim; Byung Guk Kim; Sung Won Kim; Soo Whan Kim
Journal:  Int Forum Allergy Rhinol       Date:  2019-02-21       Impact factor: 3.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.